Sign in
4

Changes in Ownership

Arcutis Biotherapeutics, Inc. Filed Acc 0001628280-26-014326

Matsuda Masaru sold 12,058 shares at an average $26.03 ($313,877)

  • Matsuda Masaru acquired 37,000 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Matsuda Masaru

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-27 Grant or award : show line 1 in the form 10b5-1 +37,000 147,003 D
2026-02-27 Sale : show line 2 in the form 10b5-1 −3,325 $27.95 $92,934 143,678 D
2026-03-02 Sale : show line 3 in the form 10b5-1 −6,553 $25.16 $164,876 137,125 D
2026-03-02 Sale : show line 4 in the form 10b5-1 −193 $25.91 $5,001 136,932 D
2026-03-02 Sale : show line 5 in the form 10b5-1 −1,987 $25.70 $51,066 136,932 D
Open-market sales · 12,058 sh · avg $26.03 · $313,877

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-27 Grant or award : show line 6 in the form 10b5-1 Stock Option (right to buy) +97,000 97,000 D
Loading xslF345X05/wk-form4_1772588538.xml…